09/08/2025
One year use in people living with type-1 & was associated with:
1) 15.7% weight loss
2) 0.58% additional lowering of HbA1c
3) 36% reduction in total daily dose of insulin requirement
4) Reduced hypoglycaemia & glycaemic variability (blood glucose fluctuations)
Tirzepatide indeed does make life easier in T1D with obesity!
Details at: https://liebertpub.com/doi/epdf/10.1089/dtom.2025.0048